Showing results (1-10 of 742) with videos related to
Sort By:
Pageof 75
Japan-Hospitals : the Journal of the Japan Hospital Association|February 7, 2009
Comfortable hospital with breathing boardsKunio Hashiguchi, Kenji Hashimoto, Masaru AkaoPsychiatry and Clinical Neurosciences|June 20, 2019
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspectiveKenji HashimotoThe Open Medicinal Chemistry Journal|January 22, 2011
Glycine transport inhibitors for the treatment of schizophreniaKenji HashimotoProgress in Neuro-Psychopharmacology & Biological Psychiatry|July 6, 2010
The role of glutamate on the action of antidepressantsKenji HashimotoCNS & Neurological Disorders Drug Targets|August 26, 2009
Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?Kenji HashimotoCancers|June 2, 2021
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug DevelopmentKenji HashimotoExpert Opinion on Therapeutic Targets|June 27, 2014
Targeting of NMDA receptors in new treatments for schizophreniaKenji HashimotoBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 18, 2007
BDNF variant linked to anxiety-related behaviorsKenji HashimotoBiochemical Pharmacology|April 1, 2020
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamineKenji HashimotoPageof 75